NeoGenomics, Inc. Share Price OTC Bulletin Board
Equities
US64049M2098
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
||
- USD | - |
|
28/05 | NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO | CI |
02/05 | North American Morning Briefing : Stock Futures -3- | DJ |
Sales 2024 * | 66Cr 5.47TCr | Sales 2025 * | 72Cr 6TCr | Capitalization | 173.43Cr 14TCr |
---|---|---|---|---|---|
Net income 2024 * | -7.2Cr -600.63Cr | Net income 2025 * | -4.7Cr -392.08Cr | EV / Sales 2024 * | 3.05 x |
Net Debt 2024 * | 27Cr 2.21TCr | Net Debt 2025 * | 24Cr 1.98TCr | EV / Sales 2025 * | 2.74 x |
P/E ratio 2024 * |
-23.8
x | P/E ratio 2025 * |
-37.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.75% |
Latest transcript on NeoGenomics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Chris Smith
CEO | Chief Executive Officer | 61 | 15/22/15 |
Lynn Tetrault
CHM | Chairman | 61 | 12/15/12 |
Jeffrey Sherman
DFI | Director of Finance/CFO | 58 | 07/22/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Kelly
BRD | Director/Board Member | 67 | 15/20/15 |
Chris Smith
CEO | Chief Executive Officer | 61 | 15/22/15 |
David Perez
BRD | Director/Board Member | 63 | 03/22/03 |
1st Jan change | Capi. | |
---|---|---|
-19.42% | 845.66Cr | |
+71.50% | 440.55Cr | |
+12.77% | 287.54Cr | |
-57.49% | 170.08Cr | |
-16.46% | 150.08Cr | |
+21.44% | 125.04Cr | |
-49.06% | 103.37Cr | |
+16.01% | 97Cr | |
-16.56% | 88Cr |